ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
ILLUMINA, INC.
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Jul 31, 2026
$262.66+0.12 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $40.19B
- P/E (TTM)
- 48.8
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
66.1%−1.9 pts over 5 years
Operating margin
18.6%+0.7 pts over 5 years
Net margin
19.6%−0.7 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -0.7% | -1.8% | +6.0% | +6.9% | |
| Gross profit | +0.3% | -1.2% | +5.4% | +6.4% | |
| Operating income | – | – | +6.8% | +2.8% | |
| Net income | – | – | +5.3% | +6.3% | |
| EPS, diluted | – | – | +4.1% | +5.8% | |
| Free cash flow | +31.3% | +106.3% | +0.9% | +3.8% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 22.9% | 14.1% | 33.4% | |
| Return on assets | 11.6% | 8.8% | 13.1% | |
| Current ratio | 3.29 | 3.60 | 2.08 | |
| Debt to equity | 0.48 | 0.25 | 0.55 | |
| Net debt to EBITDA | 0.44× | -0.82× | 0.07× | |
| Interest coverage | 17.8× | 11.8× | 8.0× | |
| Inventory turnover | 2.6× | 2.8× | 2.7× | |
| Capex to revenue | 10.8% | 5.8% | 3.4% | |
| Diluted shares | 148M | 148M | 156M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Illumina generated $3.33B from operations and spent $1.82B on capital expenditure, dividends and share buybacks. 53% of that went back into the business.
Generated
$3.33B
Used
$1.82B
Capital expenditure$965.00M53%Dividends$00%Share buybacks$858.00M47%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin19.6%
×Asset turnover0.67×
×Equity multiplier2.54×
=Return on equity, FY202533.4%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 19.6% | 0.67× | 2.54× | 33.4% |
| FY2024 | -28.0% | 0.53× | 2.02× | -30.1% |
| FY2023 | -25.8% | 0.40× | 1.81× | -18.8% |
| FY2022 | -96.1% | 0.33× | 1.58× | -50.8% |
| FY2021 | 16.8% | 0.40× | 1.48× | 9.9% |
| FY2020 | 20.3% | 0.43× | 1.60× | 14.1% |
| FY2019 | 28.3% | 0.50× | 1.71× | 23.9% |
| FY2018 | 24.8% | 0.55× | 1.88× | 25.4% |
| FY2017 | 26.4% | 0.58× | 1.93× | 29.4% |
| FY2016 | 19.3% | 0.60× | 1.97× | 22.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
9of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$850.00M
- Cash generatingOperating cash flow above zero$1.08B
- Return on assets improvedROA up on the prior year-12.1% → 13.5%
- Earnings backed by cashOperating cash flow above net income$1.08B vs $850.00M
- Less leverageLong-term debt to assets fell23.6% → 22.4%
- Better liquidityCurrent ratio rose1.78 → 2.08
- No dilutionShare count did not rise159M → 156M
- Gross margin improvedGross margin up on the prior year65.44% → 66.08%
- More efficientAsset turnover rose0.43 → 0.69